中石化油服(01033.HK)非公开发行股票禁售期结束
格隆汇 1 月 18日丨中石化油服(01033.HK)发布公告,根据中国石化集团公司A股认购协议及齐心共赢计划A股认购协议,中国石化集团公司及齐心共赢计划认购的新A股的禁售期亦将于2021年1月24日结束。中国石化集团公司及齐心共赢计划分别认购的1,503,568,702股新A股和23,148,854股新A股,分别占公司已发行股份总数的7.92%和0.12%。上述新A股将于2021年1月25日可上市流通。公司相信,作为公司控股股东,中国石化集团公司及盛骏公司将继续支持集团的未来发展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.